The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Neuropsychologic Status in Multiple Sclerosis After Treatment With Glatiramer
Abstract
BACKGROUND: Glatiramer acetate (Copaxone) therapy reduces clinical disease activity in relapsing-remitting multiple sclerosis (MS). OBJECTIVE: To study the effect of glatiramer therapy on neuropsychologic function as part of a randomized, placebo-controlled, multicenter trial. METHODS: Two hundred forty-eight patients with relapsing-remitting MS and mild to moderate disability (Expanded Disability Status Scale score, <5.0) were tested before and 12 and 24 months after randomization to administration of glatiramer acetate, 20 mg/d, or matching placebo. Neuropsychologic tests examined 5 cognitive domains most often disrupted in patients with MS: sustained attention, perceptual processing, verbal and visuospatial memory, and semantic retrieval. RESULTS: Baseline neuropsychologic test performance was similar in both treatment groups and was within normal range, except for impaired semantic retrieval. Mean neuropsychologic test scores were higher at 12 and 24 months than at baseline, and no differences were detected between treatment groups over time. No significant interactions were detected between treatment and either time or baseline impairment. CONCLUSIONS: Our 2-year longitudinal study showed no effect of glatiramer therapy on cognitive function in relapsing-remitting MS. Although it is possible that glatiramer therapy has no effect on cognitive function, the lack of measurable decline in cognitive function in both patient groups for 2 years limits the opportunity for glatiramer to demonstrate a therapeutic effect by minimizing such decline. Emerging treatments for MS should continue to be examined for their effect on cognitive impairment because it can be a critical determinant of disability. A greater understanding of the natural history of cognitive decline in MS is essential for a rational design of these drug trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
Paced Auditory Serial-Addition Task: A Measure of Recovery from Concussion
Gronwall, D. M. A. (1977) · Perceptual and Motor Skills · doi:10.2466/pms.1977.44.2.367 · Cited by 2,395
Cognitive dysfunction in multiple sclerosis.: II. Impact on employment and social functioning
Rao, S. M., Leo, G. J., Ellington, L., Nauertz, T., Bernardin, L., & Unverzagt, F. (1991) · Neurology · doi:10.1212/wnl.41.5.692 · Cited by 890
Cited by
Cognitive impairment in multiple sclerosis
Chiaravalloti, N. D., & DeLuca, J. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70259-x · Cited by 2,088
Cognitive Dysfunction in Multiple Sclerosis
Guimarães, J., & Sá, M. J. (2012) · Frontiers in Neurology · doi:10.3389/fneur.2012.00074 · Cited by 427
Boringa, J. B., Lazeron, R. H., Reuling, I. E., Adèr, H. J., Pfennings, L. E., Lindeboom, J., de Sonneville, L. M., Kalkers, N. F., & Polman, C. H. (2001) · Multiple Sclerosis Journal · doi:10.1177/135245850100700409 · Cited by 297
Differences in cognitive impairment of relapsing remitting, secondary, and primary progressive MS
Huijbregts, S. C. J., Kalkers, N. F., de Sonneville, L. M. J., de Groot, V., Reuling, I. E. W., & Polman, C. H. (2004) · Neurology · doi:10.1212/01.wnl.0000129828.03714.90 · Cited by 277
The Neuropsychiatry of Multiple Sclerosis
Feinstein, A. (2004) · The Canadian Journal of Psychiatry · doi:10.1177/070674370404900302 · Cited by 252
Metadata
- Authors
- Weinstein, A., Schwid, S. I. L., Schiffer, R. B., McDermott, M. P., Giang, D. W., & Goodman, A. D.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 1999-03-01
- Volume
- 56
- Issue
- 3
- Pages
- 319
- ISSN
- 0003-9942 (ISSN-L)
- OpenAlex
- W2057005657
- Cited by
- 159
- References
- 3
- FWCI
- 3.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuropsychologic Status in Multiple Sclerosis After Treatment With Glatiramer. https://app.cochat.ai/papers/10.1001/archneur.56.3.319
- The paper
- Weinstein, A., Schwid, S. I. L., Schiffer, R. B., McDermott, M. P., Giang, D. W., & Goodman, A. D. (1999). Neuropsychologic Status in Multiple Sclerosis After Treatment With Glatiramer. Archives of Neurology. https://doi.org/10.1001/archneur.56.3.319
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.